Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Atazanavir sulfate, BMS-232632-05, CGP-73547, Reyataz, Zrivada

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

46 API Suppliers, 25 USDMF, 7 CEP/COS, 15 EU WC, 2 KDMF, 19 NDC API, 21 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

69 FDF Dossiers, 42 FDA Orange Book, 8 Europe, 11 Canada, 2 South Africa, 6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 300MG BASE;150MG, CAPSULE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 200MG BASE, CAPSULE;ORAL - EQ 300MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 8 DKSH, 4 Faran Shimi Pharmaceutical, 5 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 1 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 BASF, 6 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 17 Kerry, 3 Lonza Capsugel, 12 Microlex e.U, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 14 Roquette, 3 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 4 Silverline Chemicals, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Fillers, Diluents & Binders, 22 Disintegrants & Superdisintegrants, 19 Thickeners and Stabilizers, 16 Lubricants & Glidants, 15 Granulation, 13 Coating Systems & Additives, 13 Direct Compression, 12 Co-Processed Excipients, 8 Film Formers & Plasticizers, 8 Empty Capsules, 7 Topical, 7 Emulsifying Agents, 7 Taste Masking, 4 Controlled & Modified Release, 4 Parenteral, 4 Solubilizers, 3 Coloring Agents, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents, 2 Rheology Modifiers, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 10 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 5 Annual Reports

MARKET PLACE

1 FDF Dossiers

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 8 Health Canada Patents

REF. STANDARDS & IMPURITIES

7 USP, 1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	Granules India Limited	India	M/s Granules India Limited	WC-0024n	Atazanavir Sulphate IH/EP	2022-08-07	2025-06-26	Plot No.8, Jawaharlal Nehru Pharmacity, Tadi (V) Paravada, Visakhapatnam-531 019, Andhra Pradesh India
04/06/2025	Arene Lifesciences	India	M/s Arene Life Sciences Private Limited	WC-0487	Atazanavir Sulphate IHS	2023-12-26	2026-12-03	Plot No. 48-50, 209-211, IDA, Phase-ll, Pashamylaram, Patancheru, Sangareddy District-502307, Telangana State, India

Atazanavir Sulfate, BMS-232632-05, CGP-73547, Reyataz, Zrivada

Atazanavir sulfate, BMS-232632-05, CGP-73547, Reyataz, Zrivada

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

46 API Suppliers

25 USDMF

7 CEP/COS

15 EU WC

2 KDMF

19 NDC API

21 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

69 FDF Dossiers

42 FDA Orange Book

8 Europe

11 Canada

2 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 300MG BASE;150MG

CAPSULE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 200MG BASE

CAPSULE;ORAL - EQ 300MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

8 DKSH

4 Faran Shimi Pharmaceutical

5 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

1 Actylis

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 BASF

6 DFE Pharma

1 Finar

6 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

17 Kerry

3 Lonza Capsugel

12 Microlex e.U

2 Pharmatrans-Sanaq

4 Pluviaendo

4 Prachin Chemical

1 Qualicaps

14 Roquette

3 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

4 Silverline Chemicals

1 Valens Pharmachem

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Fillers, Diluents & Binders

22 Disintegrants & Superdisintegrants

19 Thickeners and Stabilizers

16 Lubricants & Glidants

15 Granulation

13 Coating Systems & Additives

13 Direct Compression

12 Co-Processed Excipients

8 Film Formers & Plasticizers

8 Empty Capsules

7 Topical

7 Emulsifying Agents

7 Taste Masking

4 Controlled & Modified Release

4 Parenteral

4 Solubilizers

3 Coloring Agents

3 Chewable & Orodispersible Aids

3 Surfactant & Foaming Agents

2 Rheology Modifiers

CAPSULE;ORAL - EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 150MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons